Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Patrys Limited ( (AU:PAB) ) has shared an announcement.
Patrys Limited announced the cessation of James Campbell as a director, effective November 10, 2025. This change in the board of directors may influence the company’s strategic direction and stakeholder confidence, as Campbell held a significant number of shares both personally and through Barrabool Biotechnology Pty Ltd.
More about Patrys Limited
Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies. The company is engaged in creating innovative treatments that target various diseases, leveraging its proprietary technologies to enhance therapeutic outcomes.
Average Trading Volume: 1,073,778
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$12.61M
Find detailed analytics on PAB stock on TipRanks’ Stock Analysis page.